S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q2 2026

Deep Track Capital

Period: Q2 2026 · Filed: 2026-08-14
View on SEC EDGAR
AUM
$6.87B
Total portfolio value
Positions
67
Reported securities
Top Holding
GH
7.4% $509.1M
QoQ Changes
+8 / -8
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHGUARDANT HEALTH INC$509.1M7.41%$150.03$157.21+4.8%
7.4%
IMVTIMMUNOVANT INC$359.9M5.24%$38.53$41.82+8.5%
5.2%
GPCRSTRUCTURE THERAPEUTICS INC$254.4M3.70%$53.67$54.51+1.6%
3.7%
PCVXVAXCYTE INC$250.0M3.64%$58.13$58.07-0.1%
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$248.3M3.61%$301.03$228.65-24.0%
3.6%
MANEVERADERMICS INC$245.9M3.58%$122.94$112.71-8.3%
3.6%
TARSTARSUS PHARMACEUTICALS INC$230.8M3.36%$62.94$69.20+9.9%
3.4%
NUVLNUVALENT INC$220.2M3.21%
3.2%
ALKSALKERMES PLC$209.6M3.05%$52.40$49.06-6.4%
3.0%
OCULOCULAR THERAPEUTIX INC$193.3M2.81%$9.82$10.04+2.2%
2.8%
BMRNBIOMARIN PHARMACEUTICAL INC$189.3M2.75%$57.22$67.36+17.7%
2.8%
NRIXNURIX THERAPEUTICS INC$187.7M2.73%$24.26$27.05+11.5%
2.7%
ORKAORUKA THERAPEUTICS INC$183.3M2.67%$95.17$111.04+16.7%
2.7%
ALMSALUMIS INC$178.7M2.60%$28.14$25.31-10.1%
2.6%
IONSIONIS PHARMACEUTICALS INC$174.4M2.54%$79.29$57.24-27.8%
2.5%
CMPSCOMPASS PATHWAYS PLC$172.1M2.50%$14.15$13.45-5.0%
2.5%
VERAVERA THERAPEUTICS INC$171.6M2.50%$42.91$31.63-26.3%
2.5%
AXSMAXSOME THERAPEUTICS INC.$171.3M2.49%$244.77$213.67-12.7%
2.5%
GMABGENMAB A/S$155.2M2.26%$27.47$31.94+16.3%
2.3%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$136.3M1.98%$19.47$16.47-15.4%
2.0%
COAGHEMAB THERAPEUTICS HLDGS INC$132.3M1.93%$36.73$54.94+49.6%
1.9%
TNGXTANGO THERAPEUTICS INC$131.3M1.91%$31.26$25.60-18.1%
1.9%
DFTXDEFINIUM THERAPEUTICS INC$129.4M1.88%$47.04$42.63-9.4%
1.9%
GRALGRAIL INC$125.3M1.82%$68.27$67.87-0.6%
1.8%
BCAXBICARA THERAPEUTICS INC$121.7M1.77%$29.69$24.28-18.2%
1.8%
MAZEMAZE THERAPEUTICS INC$111.4M1.62%$29.84$27.18-8.9%
1.6%
CLDXCELLDEX THERAPEUTICS INC NEW$109.4M1.59%$37.21$41.95+12.7%
1.6%
LBRXLB PHARMACEUTICALS INC$108.8M1.58%$32.46$47.78+47.2%
1.6%
MBXMBX BIOSCIENCES INC$95.6M1.39%$55.20$68.57+24.2%
1.4%
GHRSGH RESEARCH PLC$89.6M1.30%$26.88$29.49+9.7%
1.3%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (8)

TickerIssuerNotionalSince Filing
ALNYALNYLAM PHARMACEUTICALS INC$248.3M-24.0%
COAGHEMAB THERAPEUTICS HLDGS INC$132.3M+49.6%
GHRSGH RESEARCH PLC$89.6M+9.7%
UTHRUNITED THERAPEUTICS CORP DEL$67.0M
AVTXAVALO THERAPEUTICS INC$66.7M
ALTALTIMMUNE INC$58.5M
WGSGENEDX HOLDINGS CORP$48.1M
HROWHARROW INC$41.1M

Exited Positions (8)

TickerIssuerNotional
XBISPDR SERIES TRUST$1.28B
APLSAPELLIS PHARMACEUTICALS INC$182.3M
CNTACENTESSA PHARMACEUTICALS PLC$125.4M
BBIOBRIDGEBIO PHARMA INC$62.5M
TERNTERNS PHARMACEUTICALS INC$56.6M
GERNGERON CORP$47.3M
ANIPANI PHARMACEUTICALS INC$46.1M
SLNOSOLENO THERAPEUTICS INC$36.1M

Increased (8)

TickerIssuerNotionalShares ΔSince Filing
MANEVERADERMICS INC$214.3M+300.0%-8.3%
BMRNBIOMARIN PHARMACEUTICAL INC$124.3M+187.6%+17.7%
VRDNVIRIDIAN THERAPEUTICS INC$38.7M+157.7%
CLDXCELLDEX THERAPEUTICS INC NEW$68.6M+128.9%+12.7%
COGTCOGENT BIOSCIENCES INC$38.9M+100.0%
GMABCALLGENMAB A/S$56.9M+54.2%+16.3%
TNGXTANGO THERAPEUTICS INC$73.8M+52.7%-18.1%
PSNLPERSONALIS INC$34.5M+33.3%

Trimmed (8)

TickerIssuerNotionalShares ΔSince Filing
IMCRIMMUNOCORE HLDGS PLC$-48.4M-83.9%
CYTKCYTOKINETICS INC$-30.9M-49.1%
MBXMBX BIOSCIENCES INC$13.3M-37.2%+24.2%
AXSMAXSOME THERAPEUTICS INC.$-14.6M-36.4%-12.7%
IVAINVENTIVA SA$-3.8M-34.6%
ENTAENANTA PHARMACEUTICALS INC$-3.7M-26.2%
KURAKURA ONCOLOGY INC$0.2M-25.2%
DYNDYNE THERAPEUTICS INC$-2.9M-25.0%
Back to Hedge Funds